Bioactive components to inhibit foam cell formation in atherosclerosis

Area of Science:

• Pharmacology and Herbal Medicine
• Cardiovascular Research
• Cell Biology

Background:

• Foam cell formation, driven by oxidized low-density lipoprotein uptake in macrophages, is central to atherosclerotic lesion development.
• Key factors influencing foam cell formation include scavenger receptor expression, cholesterol transporter activity, and esterase enzyme activity.
• Herbal therapies have demonstrated potential in managing various health conditions.

Purpose of the Study:

• To investigate the efficacy of medicinal plants and their bioactive components in suppressing foam cell formation.
• To explore plant-derived compounds as a potential therapeutic strategy for atherosclerosis management.
• To identify novel plant-based medications targeting cellular processes in foam cell generation.

Main Methods:

• Analysis of bioactive components from medicinal plants.
• Assessment of inhibitory effects on foam cell formation pathways.
• Evaluation of impacts on cholesterol transporter and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) expression.
• Investigation of effects on acyl CoA: cholesterol acyltransferase (ACAT) and neutral cholesteryl ester hydrolase (NCEH) activity.

Main Results:

• Medicinal plants and their bioactive constituents effectively suppress foam cell formation.
• Inhibition of cholesterol transporter and LOX-1 upregulation was observed.
• Suppression of ACAT and NCEH activity was demonstrated.

Conclusions:

• Plant-derived compounds offer a promising avenue for targeting foam cell generation.
• A cellular target-based therapeutic approach using plant sources can lead to novel atherosclerosis treatments.
• Further research into synthesizing new active components from plants is warranted for atherosclerosis cure.